Market Overview:
The global tetanic toxoid market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of tetanus, rising demand for preventive vaccines, and technological advancements in vaccine production. Based on type, the global tetanic toxoid market is segmented into tetanus toxin spasm and hemolytic toxin. Tetanus toxin spasm is further sub-segmented into monovalent and bivalent types. Hemolytic toxin is further sub-segmented into diphtheria and non-diphtheria types. Based on application, the global tetanic toxoid market is segmented into hospitals, clinics, ambulatory surgical centers (ASCs), and other applications such as research laboratories and veterinary clinics. Geographically, the global tetanic toxoid market is segmented into North America, Latin America, Europe Asia Pacific (APAC),and Middle East & Africa (MEA).
Product Definition:
A tetanic toxoid is a vaccine against tetanus, a serious bacterial infection that can cause muscle spasms and breathing problems. Tetanus is caused by the bacterium Clostridium tetani, which enters the body through broken skin. The tetanic toxoid vaccine helps protect against this infection.
Tetanus Toxin Spasm:
Tetanus toxin spasm is a medical condition that occurs when the body has difficulty relaxing muscle groups. This leads to rigidity of the muscles which can result in painful spasms. The most common symptom of this disease is tightness or stiffness in the neck, shoulders, and back; however it may affect any part of the body including legs, arms and stomach. Tetanus toxin spasm also causes pain in chest and lungs due to restricted breathing ability caused by contracted muscles.
Hemolytic Toxin:
Hemolytic toxin is a protein that causes the destruction of red blood cells by causing them to clump together. It's most commonly found in species of sea breams, ameres, and tunas. The amount of hemolytic toxin present in a given quantity of fish meat varies widely from species to species; for instance, tilefish have been reported to contain up to 1% while some anchovy contain as much as 20%.
Application Insights:
Based on application, the market is segmented into hospitals, clinics and ambulatory surgical centers. The clinics and ambulatory surgical centers held the largest share of the market in 2017. This is due to factors such as increasing awareness about immunization against tetanus among people, high demand for primary healthcare services and growing emphasis on reducing hospital stay duration. According to a study published by WHO in 2015, it was found that approximately 50% of patients who suffer from lockjaw are diagnosed late because of lack of timely diagnosis; this factor is anticipated to boost demand for tetanic toxoid injections over the forecast period.
The hospitals segment is expected to witness lucrative growth during the forecast period owing to factors such as an increase in incidence rate of tetanus across various regions coupled with rising awareness about immunization against this disease within these regions especially after its eradication through mass vaccination campaigns conducted several years ago.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-developed healthcare infrastructure and high awareness levels coupled with relatively higher per capita income are some major factors responsible for its large share. Moreover, increasing incidence of non-fatal & fatal cases oflockjaw&brachial plexus injuries, rising prevalence of chronic diseases such as diabetes and cancer is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to improving healthcare facilities in emerging countries such as China & India along with growing investments by international players for expanding their business operations within this region. Furthermore, increasing numberlockof road accidentsin this region due to lackof proper safety equipmentis further anticipatedto boostthe tetanic toxoid demand duringthe forecast period.
Growth Factors:
- Increasing incidence of tetanus: The incidence of tetanus is increasing globally due to various reasons such as lack of awareness, unhygienic conditions, and improper immunization. This is expected to drive the demand for tetanic toxoid vaccine in the coming years.
- Growing number of travelers: The number of travelers is increasing rapidly across the globe due to globalization and rising income levels. This is expected to create a high demand for tetanic toxoid vaccine in the near future.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as cancer, diabetes, and heart disease is increasing at an alarming rate across the world. This has led to an increase in the demand for preventive vaccines such as tetanic toxoid vaccine which can help reduce their risk significantly.
Scope Of The Report
Report Attributes
Report Details
Report Title
Tetanic Toxoid Market Research Report
By Type
Tetanus Toxin Spasm, Hemolytic Toxin
By Application
Hospitals, Clinics, Ambulatory Surgical Centers
By Companies
BB-NCIPD, Bio Farma, Biological E, Sanofi, GlaxoSmithKline, Accord Healthcare Inc, Shanha Biotechniques
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
225
Number of Tables & Figures
158
Customization Available
Yes, the report can be customized as per your need.
Global Tetanic Toxoid Market Report Segments:
The global Tetanic Toxoid market is segmented on the basis of:
Types
Tetanus Toxin Spasm, Hemolytic Toxin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BB-NCIPD
- Bio Farma
- Biological E
- Sanofi
- GlaxoSmithKline
- Accord Healthcare Inc
- Shanha Biotechniques
Highlights of The Tetanic Toxoid Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tetanus Toxin Spasm
- Hemolytic Toxin
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tetanic Toxoid Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tetanic toxoid is a vaccine that helps protect people from tetanus. Tetanus is a serious infection caused by the bacterium Clostridium tetani. The disease can cause severe muscle spasms and death if not treated quickly. Tetanic toxoid helps prevent infection by protecting people against the toxin produced by C. tetani.
Some of the key players operating in the tetanic toxoid market are BB-NCIPD, Bio Farma, Biological E, Sanofi, GlaxoSmithKline, Accord Healthcare Inc, Shanha Biotechniques.
The tetanic toxoid market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tetanic Toxoid Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tetanic Toxoid Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tetanic Toxoid Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tetanic Toxoid Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tetanic Toxoid Market Size & Forecast, 2018-2028
4.5.1 Tetanic Toxoid Market Size and Y-o-Y Growth
4.5.2 Tetanic Toxoid Market Absolute $ Opportunity
Chapter 5 Global Tetanic Toxoid Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Tetanic Toxoid Market Size Forecast by Type
5.2.1 Tetanus Toxin Spasm
5.2.2 Hemolytic Toxin
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Tetanic Toxoid Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Tetanic Toxoid Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Ambulatory Surgical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tetanic Toxoid Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tetanic Toxoid Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Tetanic Toxoid Analysis and Forecast
9.1 Introduction
9.2 North America Tetanic Toxoid Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Tetanic Toxoid Market Size Forecast by Type
9.6.1 Tetanus Toxin Spasm
9.6.2 Hemolytic Toxin
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Tetanic Toxoid Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Ambulatory Surgical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Tetanic Toxoid Analysis and Forecast
10.1 Introduction
10.2 Europe Tetanic Toxoid Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Tetanic Toxoid Market Size Forecast by Type
10.6.1 Tetanus Toxin Spasm
10.6.2 Hemolytic Toxin
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Tetanic Toxoid Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Ambulatory Surgical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Tetanic Toxoid Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Tetanic Toxoid Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Tetanic Toxoid Market Size Forecast by Type
11.6.1 Tetanus Toxin Spasm
11.6.2 Hemolytic Toxin
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Tetanic Toxoid Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Ambulatory Surgical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Tetanic Toxoid Analysis and Forecast
12.1 Introduction
12.2 Latin America Tetanic Toxoid Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Tetanic Toxoid Market Size Forecast by Type
12.6.1 Tetanus Toxin Spasm
12.6.2 Hemolytic Toxin
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Tetanic Toxoid Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Ambulatory Surgical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Tetanic Toxoid Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Tetanic Toxoid Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Tetanic Toxoid Market Size Forecast by Type
13.6.1 Tetanus Toxin Spasm
13.6.2 Hemolytic Toxin
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Tetanic Toxoid Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Ambulatory Surgical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tetanic Toxoid Market: Competitive Dashboard
14.2 Global Tetanic Toxoid Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BB-NCIPD
14.3.2 Bio Farma
14.3.3 Biological E
14.3.4 Sanofi
14.3.5 GlaxoSmithKline
14.3.6 Accord Healthcare Inc
14.3.7 Shanha Biotechniques
